Skip to main content

ADVERTISEMENT

intravascular lithotripsy

Case Report
03/24/2022

Qais Radaideh, MD, MS1; Nagarjuna Gujjula, MD1; Ann E. Narmi, MD1; Nicolas W. Shammas, MD, MS2; Toufik Mahfood Haddad, MD1

 

1Division of Cardiovascular Diseases, Creighton University School of Medicine, Omaha, Nebraska; 2Midwest Cardiovascular Research Foundation, Davenport, Iowa

Qais Radaideh, MD, MS1; Nagarjuna Guj...
The effectiveness of coronary lithotripsy as a bailout approach.
The effectiveness of coronary lithotripsy as a bailout approach.
The effectiveness of coronary...
03/24/2022
Vascular Disease Management
Brief Contribution
12/01/2021

Yashasvi Chugh, MD1;  Jaikirshan J. Khatri, MD2;  Mehdi H. Shishehbor, DO, MPH, PhD3;  Subhash Banerjee, MD4;  Kevin Croce, MD5;  Khaldoon Alaswad, MD6;  Bilal Murad, MD1;  Santiago Garcia, MD1;  M. Nicholas Burke, MD1;  Emmanouil S. Brilakis, MD, PhD1

Yashasvi Chugh, MD1;  Jaikirshan J. K...
Currently only the peripheral intravascular lithotripsy device is approved for use in the United States. We queried the United States FDA MAUDE database from January 1, 2016 to December 14, 2020 for all reports of adverse events and modes of...
Currently only the peripheral intravascular lithotripsy device is approved for use in the United States. We queried the United States FDA MAUDE database from January 1, 2016 to December 14, 2020 for all reports of adverse events and modes of...
Currently only the peripheral...
12/01/2021
Journal of Invasive Cardiology
Clinical Images
09/01/2021

Alfonso Jurado-Román, MD, PhD;  Artemio García, MD;  Raúl Moreno, MD, PhD

Alfonso Jurado-Román, MD, PhD;  Artem...
A 61-year-old patient presented an acute occlusion of the mid-right coronary artery.
A 61-year-old patient presented an acute occlusion of the mid-right coronary artery.
A 61-year-old patient presented...
09/01/2021
Journal of Invasive Cardiology
Interview
07/19/2021

William A. Gray, MD1; Christopher J. White, MD2

 

1Main Line Health, Lankenau Heart Group, Wynnewood, Pennsylvania; 2Ochsner Medical Center, New Orleans, Louisiana

William A. Gray, MD1; Christopher J. ...
A brief trial summary and interviews with William A. Gray, MD, and Christopher J. White, MD, regarding the DISRUPT PAD trial.
A brief trial summary and interviews with William A. Gray, MD, and Christopher J. White, MD, regarding the DISRUPT PAD trial.
A brief trial summary and...
07/19/2021
Vascular Disease Management
The Utility of Peripheral Intravascular Lithotripsy in Calcific Coronary Artery Disease: A Case Series
BRIEF COMMUNICATION
04/01/2021

Brett B. Yarusi, MD1;  Vikrant S. Jagadeesan, MD2;  Arif Jivan, MD, PhD2;
Erin D. Unger, MD2;  Lowie M.R. Van Assche, MD2;  Tim S. Provias, MD, MPH2; James D. Flaherty, MD2;  Keith H. Benzuly, MD2;  Daniel R. Schimmel, MD, MS2

Brett B. Yarusi, MD1;  Vikrant S. Jag...
We performed a retrospective review of patients who were excluded from preapproval trials of coronary IVL and underwent CAC modification with the off-label use of a peripheral IVL system.
We performed a retrospective review of patients who were excluded from preapproval trials of coronary IVL and underwent CAC modification with the off-label use of a peripheral IVL system.
We performed a retrospective...
04/01/2021
Journal of Invasive Cardiology
The STAND Trial: How the MicroStent Attempts to Break Through Barriers in Below-the-Knee CLI
Clinical Update
05/21/2020

Omosalewa Adenikinju, MD; Michael Patel, MD; Adam Zybulewski, MD; Brandon Olivieri, MD; Robert E. Beasley, MD

Mount Sinai Medical Center, Miami Beach, Florida

Omosalewa Adenikinju, MD; Michael Pat...
To understand the intent behind the STAND (Clinical Evaluation of the MicroSTent PeripherAl Vascular SteNt in Subjects with Arterial Disease Below the Knee) trial, one must comprehend the barriers of clinical success in BTK revascularization.
To understand the intent behind the STAND (Clinical Evaluation of the MicroSTent PeripherAl Vascular SteNt in Subjects with Arterial Disease Below the Knee) trial, one must comprehend the barriers of clinical success in BTK revascularization.
To understand the intent behind...
05/21/2020
Vascular Disease Management
Treatment of Common Femoral Artery Lesions Involving the Superficial and Profunda Femoral Artery Bifurcation
Original Research
05/15/2020

Alberto Cereda, MD1; Paolo Cioffi, MD1; Riccardo Iorio, MD1; Attilio Cotroneo, MD2; Giuseppe Celano, MD1; Sante Bongo, MD1; Gaetano Chiricolo, MD3; Giuseppe Sangiorgi, MD3

1Department of Cardiology and 2Department of Vascular Surgery, Clinica San Gaudenzio, Novara, Italy; 3Department of Systemic Medicine, Institute of Cardiology, University of Tor Vergata, Rome, Italy

Alberto Cereda, MD1; Paolo Cioffi, MD...
The authors repot on 2 cases at high risk for surgical CFE treated respectively with directional atherectomy and intravascular lithotripsy, with good clinical success both in short- and long-term follow-up.
The authors repot on 2 cases at high risk for surgical CFE treated respectively with directional atherectomy and intravascular lithotripsy, with good clinical success both in short- and long-term follow-up.
The authors repot on 2 cases at...
05/15/2020
Vascular Disease Management